Anne-c Jensen-Bay
Herlev, Denmark
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Identification of patient endotypes and adalimumab treatment responders in axial spondyloarthritis using blood-derived extracellular matrix biomarkers.
Journal: RMD open
Published: September 28, 2023
Dysregulation of circulating collagen turnover markers in very early systemic sclerosis.
Journal: RMD open
Published: May 10, 2023
Neuropathic pain in the IMI-APPROACH knee osteoarthritis cohort: prevalence and phenotyping.
Journal: RMD open
Published: October 14, 2021
Publisher Correction: Metabolites of type I, II, III, and IV collagen may serve as markers of disease activity in axial spondyloarthritis.
Journal: Scientific reports
Published: August 21, 2020
The Anti-ADAMTS-5 Nanobody® M6495 Protects Cartilage Degradation Ex Vivo.
Journal: International journal of molecular sciences
Published: July 01, 2020
Citrullinated vimentin and biglycan protein fingerprints as candidate serological biomarkers for disease activity in systemic sclerosis: a pilot study.
Journal: Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals
Published: November 21, 2018
Correlation between serological biomarkers of extracellular matrix turnover and lung fibrosis and pulmonary artery hypertension in patients with systemic sclerosis.
Journal: International journal of rheumatic diseases
Published: November 17, 2018
Is radiographic progression in radiographic axial spondyloarthritis related to matrix metalloproteinase degradation of extracellular matrix?
Journal: RMD open
Published: January 10, 2018
Translational Biomarkers and Ex Vivo Models of Joint Tissues as a Tool for Drug Development in Rheumatoid Arthritis.
Journal: Arthritis & rheumatology (Hoboken, N.J.)
Published: May 19, 2017
Last Updated: 09/26/2026